MRI Screening of Placenta Adhesion Abnormalities

Recruiting now · Not applicable

Conditions studied: Placenta; Implantation

In brief

Placenta Adhesion Abnormalities (PAA) are the consequence of an excessive invasion of the placenta within the myometrium. PAA are related to severe maternal pregnancy outcomes, especially in case of incidental discovery during delivery that increase the risk of intraoperative massive bleeding, hysterectomy and even maternal death. Ultrasound is the standard modality for diagnosing PAA, but Magnetic Resonance Imaging (MRI) has been increasingly performed in the case of inconclusive sonographic findings. However, standard morphological MRI sequences appear as insufficient to improve the sensitivity and specificity values for detecting PAA, while quantitative MRI may be more efficient. The main objective of this study is to characterize the diagnostic performance of quantitative MRI parameters (mainly Apparent Diffusion Coefficient, T2 and T2\*) reflecting placental perfusion and/or oxygenation at high field, without injection of gadolinium-based agent, for the detection of PAA in women with ongoing pregnancy between 30 and 38 weeks of gestation with risk factors for PPA.

Key facts

Study ID

NCT04328532

Run by

Central Hospital, Nancy, France

People needed

71

Starts

2020-10-21

Expected to finish

2026-10-21

Last updated by the study team

2026-06-16

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Pregnant participant between 30 and 38 weeks of gestation,
• Age ≥18 years old,
• Participant who completed the preliminary medical examination,
• Participant who has received full information about the organization of the research and has signed her informed consent.
• Participant planning to give birth at CHRU of Nancy
• Participant presenting risk factors for PAA : low-lying or covering placenta or in front of the uterine scar.

You may not qualify if…

• Multiple pregnancy,
• Participant presenting at least one contraindication or restriction to performing an MRI as described in the protocol, in accordance with the current recommendations,
• Participant unable to understand or follow study procedure,
• Person referred to in Articles L. 1121-6 to L. 1121-8, L1122-2 and L. 1122-1-2 of the Public Health Code.

Where it is running

• Centre Hospitalier Régional Universitaire de Nancy — Vandœuvre-lès-Nancy, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.